Question 1

What is the catalog number for N, N-dimethyl-N-[2-phenyl-4- (1,1,1-triphenylphosphonio) -1,3-oxazol-5-yl]amine iodide?

Accepted Answer

The catalog number for N, N-dimethyl-N-[2-phenyl-4- (1,1,1-triphenylphosphonio) -1,3-oxazol-5-yl]amine iodide is OR28218.

Question 2

Is N, N-dimethyl-N-[2-phenyl-4- (1,1,1-triphenylphosphonio) -1,3-oxazol-5-yl]amine iodide in stock?

Accepted Answer

N, N-dimethyl-N-[2-phenyl-4- (1,1,1-triphenylphosphonio) -1,3-oxazol-5-yl]amine iodide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 4

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 5

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

N, N-dimethyl-N-[2-phenyl-4- (1,1,1-triphenylphosphonio) -1,3-oxazol-5-yl]amine iodide

Product Specifications

CAS Number

MDL Number

Smiles

Frequently Asked Questions

Explore Other Products

CD86 (BU63), CF405S conjugate, 0.1mg/mL

HLA-DRB (HLA-DRB/1067), Biotin conjugate, 0.1mg/mL

SOX9 / SRY-box 9 (SOX9/2387), CF647 conjugate, 0.1mg/mL

Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL

S100A9 + Calprotectin (S100A8/A9 Complex) (MAC3157R), CF647 conjugate, 0.1mg/mL

SEC62 Recombinant Rabbit Monoclonal Antibody [PSH0-25]